Claude Pichard
Research Subjects
Claude Pichard has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
L. Genton
5 shared publicationsS. Graf
4 shared publicationsUrsula G. Kyle
Clinical Nutrition and Diet Therapy, Geneva University Hospital, 1211 Geneva, Switzerland
4 shared publicationsDaniel O. Slosman
Geneva University Hospital
3 shared publicationsAlfredo Morabia
Geneva University Hospital
2 shared publicationsC.-P. Heidegger
2 shared publications
Latest Publications
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S113
SUN-P159: Severe Pain Intensity is Associated with Insufficient Energy Intake in Hospitalised Patients
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S113
SUN-P159: Severe Pain Intensity is Associated with Insufficient Energy Intake in Hospitalised Patients
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S129-S130
SUN-P205: Indication and Prescription of Oral Nutritional Supplements in a Swiss University Hospital
- 1 September 2017
- Published by Elsevier in Clinical Nutrition
- Vol. 36, S129-S130
SUN-P205: Indication and Prescription of Oral Nutritional Supplements in a Swiss University Hospital
- 1 September 2014
- Published by Elsevier in Clinical Nutrition
- Vol. 33, S28
PP025-SUN: High Risk of Underfeeding during the First ICU Week Results also from Insufficient Energy Prescription
- 1 September 2014
- Published by Elsevier in Clinical Nutrition
- Vol. 33, S28
PP025-SUN: High Risk of Underfeeding during the First ICU Week Results also from Insufficient Energy Prescription
- 1 September 2014
- Published by Elsevier in Clinical Nutrition
- Vol. 33, S27
PP023-SUN: Composition of the Standard Ready-To Use Solutions does not Match Recommended Macronutrient Targets in Intensive Care Unit (ICU)
- 1 September 2014
- Published by Elsevier in Clinical Nutrition
- Vol. 33, S27
PP023-SUN: Composition of the Standard Ready-To Use Solutions does not Match Recommended Macronutrient Targets in Intensive Care Unit (ICU)
- Open Access
- 1 December 2001
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 86 (6) , 725-731
Contribution of body composition to nutritional assessment at hospital admission in 995 patients: a controlled population study
Body weight, weight changes and BMI are easily obtainable indicators of nutritional status, but they do not provide information on the amount of fat-free and fat masses. The purpose of the present study was to determine if fat-free mass (FFM) and fat mass were depleted in patients with normal BMI or serum albumin at hospital admission. A group of 995 consecutive patients were evaluated for malnutrition by BMI, serum albumin, and 50 kHz bioelectrical impedance analysis and compared with 995 healthy adults, matched for age and height, and then compared with FFM and fat mass percentiles previously determined in 5225 healthy adults. A BMI of ≤20 kg/m2 was noted in 17·3 % of patients and serum albumin of ≤35 g/l was found in 14·9 % of patients. In contrast, 31 % of all patients were below the tenth percentile for FFM, compared with 10·1 % of controls (χ2, P=0·0001), while 73 % of patients with BMI ≤20 kg/m2 and 31 % of patients with BMI 20–24·9 kg/m2 fell below the tenth percentile for FFM. Furthermore, the FFM was lower in patients than controls and the differences with age in FFM (lower) and fat mass (higher) were greater in patients than in controls. BMI and albumin significantly underestimated the prevalence of malnutrition in patients at hospital admission compared with body composition measurements. Optimal nutritional assessment should therefore include objective measurement of FFM and fat mass.
- 1 December 2001
- Published by Cambridge University Press (CUP) in British Journal of Nutrition
- Vol. 86 (6) , 725-731
Open AccessContribution of body composition to nutritional assessment at hospital admission in 995 patients: a controlled population study
Body weight, weight changes and BMI are easily obtainable indicators of nutritional status, but they do not provide information on the amount of fat-free and fat masses. The purpose of the present study was to determine if fat-free mass (FFM) and fat mass were depleted in patients with normal BMI or serum albumin at hospital admission. A group of 995 consecutive patients were evaluated for malnutrition by BMI, serum albumin, and 50 kHz bioelectrical impedance analysis and compared with 995 healthy adults, matched for age and height, and then compared with FFM and fat mass percentiles previously determined in 5225 healthy adults. A BMI of ≤20 kg/m2 was noted in 17·3 % of patients and serum albumin of ≤35 g/l was found in 14·9 % of patients. In contrast, 31 % of all patients were below the tenth percentile for FFM, compared with 10·1 % of controls (χ2, P=0·0001), while 73 % of patients with BMI ≤20 kg/m2 and 31 % of patients with BMI 20–24·9 kg/m2 fell below the tenth percentile for FFM. Furthermore, the FFM was lower in patients than controls and the differences with age in FFM (lower) and fat mass (higher) were greater in patients than in controls. BMI and albumin significantly underestimated the prevalence of malnutrition in patients at hospital admission compared with body composition measurements. Optimal nutritional assessment should therefore include objective measurement of FFM and fat mass.
- 1 November 2001
- Vol. 61 (21) , 7971-7
Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low DNA-incorporation rates. We evaluated whether blocking of thymidine (dThd) synthesis by 5-fluoro-2'-deoxyuridine (FdUrd) could improve scintigraphy with radio-dThd analogues, such as 5-iodo-2'-deoxyuridine (IdUrd). We first show in vitro that coincubation with FdUrd substantially increased incorporation of [125I]IdUrd and [3H]dThd in the three tested human glioblastoma lines. Flow cytometry analysis showed that a short coincubation with FdUrd (1 h) produces a signal increase per labeled cell. We then measured biodistribution 24 h after i.v. injection of [125I]IdUrd in nude mice s.c. xenografted with the three glioblastoma lines. Compared with animals given [125I]IdUrd alone, i.v. preadministration for 1 h of 10 mg/kg FdUrd increased the uptake of [125I]IdUrd in the three tumors 4.8-6.8-fold. Compatible with previous reports, there were no side effects in mice observed for 2 months after receiving such a treatment. The tumor uptake of [125I]IdUrd was increased < or =13.6-fold when FdUrd preadministration was stepwise reduced to 1.1 mg/kg. Uptake increases remained lower (between 1.7- and 5.8-fold) in normal proliferating tissues (i.e., bone marrow, spleen, and intestine) and negligible in quiescent tissues. DNA extraction showed that 72-80% of radioactivity in tumor and intestine was bound to DNA. Scintigraphy of xenografted mice was performed at different times after i.v. injection of 3.7 MBq [125I]IdUrd. Tumor detection was significantly improved after FdUrd preadministration while still equivocal after 24 h in mice given [125I]IdUrd alone. Furthermore, background activity could be greatly reduced by p.o. administration of KClO4 in addition to potassium iodide. We conclude that FdUrd preadministration may improve positron or single photon emission tomography with cell division tracers, such as radio-IdUrd and possibly other dThd analogues.
- 1 November 2001
- Vol. 61 (21) , 7971-7
Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Use of radiolabeled nucleotides for tumor imaging is hampered by rapid in vivo degradation and low DNA-incorporation rates. We evaluated whether blocking of thymidine (dThd) synthesis by 5-fluoro-2'-deoxyuridine (FdUrd) could improve scintigraphy with radio-dThd analogues, such as 5-iodo-2'-deoxyuridine (IdUrd). We first show in vitro that coincubation with FdUrd substantially increased incorporation of [125I]IdUrd and [3H]dThd in the three tested human glioblastoma lines. Flow cytometry analysis showed that a short coincubation with FdUrd (1 h) produces a signal increase per labeled cell. We then measured biodistribution 24 h after i.v. injection of [125I]IdUrd in nude mice s.c. xenografted with the three glioblastoma lines. Compared with animals given [125I]IdUrd alone, i.v. preadministration for 1 h of 10 mg/kg FdUrd increased the uptake of [125I]IdUrd in the three tumors 4.8-6.8-fold. Compatible with previous reports, there were no side effects in mice observed for 2 months after receiving such a treatment. The tumor uptake of [125I]IdUrd was increased < or =13.6-fold when FdUrd preadministration was stepwise reduced to 1.1 mg/kg. Uptake increases remained lower (between 1.7- and 5.8-fold) in normal proliferating tissues (i.e., bone marrow, spleen, and intestine) and negligible in quiescent tissues. DNA extraction showed that 72-80% of radioactivity in tumor and intestine was bound to DNA. Scintigraphy of xenografted mice was performed at different times after i.v. injection of 3.7 MBq [125I]IdUrd. Tumor detection was significantly improved after FdUrd preadministration while still equivocal after 24 h in mice given [125I]IdUrd alone. Furthermore, background activity could be greatly reduced by p.o. administration of KClO4 in addition to potassium iodide. We conclude that FdUrd preadministration may improve positron or single photon emission tomography with cell division tracers, such as radio-IdUrd and possibly other dThd analogues.
- 24 July 2001
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 55 (8) , 663-672
Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years
European Journal of Clinical Nutrition is a high quality, peer-reviewed journal that covers all aspects of human nutrition.
- 24 July 2001
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 55 (8) , 663-672
Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years
European Journal of Clinical Nutrition is a high quality, peer-reviewed journal that covers all aspects of human nutrition.
- 1 November 2000
- Vol. 151 (7) , 575-583
[Assessment of nutritional status].
Malnutrition is an important factor which influences both the morbidity and the recovery. Assessment of the initial nutritional status, then its evolution during the disease and/or treatment, plays an important role for tailoring the nutritional support. This assessment allows to specify the nutritional needs and body reserves, as well as the metabolic and immunologic functions. The global nutritional assessment is aimed at defining if the patient is: well nourished, slightly or severely malnourished, and if the aetiologies of the existing malnutrition will disappear, increase or decrease. This conclusion correlates the nutritional assessment to the dynamic of the pathology and highlights if the nutritional support has to be immediate or delayed, maximal or partial. No single method allows to detect PCM, except in very severe cases. The diagnosis of PCM results of various clinical, biological and functional informations. This review describes the main methods and suggests practical modalities for nutritional assessment.
- 1 November 2000
- Vol. 151 (7) , 575-583
[Assessment of nutritional status].
Malnutrition is an important factor which influences both the morbidity and the recovery. Assessment of the initial nutritional status, then its evolution during the disease and/or treatment, plays an important role for tailoring the nutritional support. This assessment allows to specify the nutritional needs and body reserves, as well as the metabolic and immunologic functions. The global nutritional assessment is aimed at defining if the patient is: well nourished, slightly or severely malnourished, and if the aetiologies of the existing malnutrition will disappear, increase or decrease. This conclusion correlates the nutritional assessment to the dynamic of the pathology and highlights if the nutritional support has to be immediate or delayed, maximal or partial. No single method allows to detect PCM, except in very severe cases. The diagnosis of PCM results of various clinical, biological and functional informations. This review describes the main methods and suggests practical modalities for nutritional assessment.